Literature DB >> 20436078

Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment.

Daniela Rollando1, Gian Paolo Bezante, Alberto Sulli, Manrico Balbi, Nicoletta Panico, Carmen Pizzorni, Simone Negrini, Claudio Brunelli, Antonio Barsotti, Maurizio Cutolo, Francesco Indiveri, Massimo Ghio.   

Abstract

OBJECTIVE: To assess possible correlations between endothelial-dependent flow-mediated dilation (FMD) of the brachial artery and nailfold videocapillaroscopy (NVC) in patients with systemic sclerosis (SSc). Evidence has shown that vascular impairment in SSc may be a sign of endothelial dysfunction involving both microvascular and macrovascular systems, although the pathological mechanisms of the dysfunction are poorly understood.
METHODS: Forty-three consecutive patients (mean age 51 +/- 11 yrs) with SSc were studied. Thirty patients had limited cutaneous SSc, 13 had diffuse cutaneous SSc. Twenty-seven healthy subjects (mean age 48 +/- 8 yrs) were recruited as controls. Ultrasound assessment of FMD was performed on all subjects in order to evaluate macrovascular function. Patients were divided into 3 patterns of microvascular damage on the basis of NVC (early, active, and late), and the microangiopathy evolution score was calculated, as reported elsewhere.
RESULTS: FMD was significantly reduced in patients with SSc compared to healthy subjects [median 8.0% (3.0%-9.0%) vs 15.0% (12.0%-16.0%), respectively; p < 0.0001]. Patients with an early pattern of microangiopathy showed reduced FMD values compared to controls (p = 0.0001). FMD was significantly reduced in patients with SSc who had the late NVC pattern of microangiopathy compared to active and early patterns (p = 0.003 and p = 0.001, respectively). FMD was inversely correlated with the microvascular damage rate in patients with SSc (p < 0.0001).
CONCLUSION: We demonstrated the simultaneous presence of macrovascular and microvascular impairment in patients with SSc, which was already present in the early phase of the vascular disease.

Entities:  

Mesh:

Year:  2010        PMID: 20436078     DOI: 10.3899/jrheum.091116

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

1.  Evaluation of arterial stiffness and hemodynamics by oscillometric method in patients with systemic sclerosis.

Authors:  Murat Sunbul; Kursat Tigen; Gulsen Ozen; Erdal Durmus; Tarik Kivrak; Altug Cincin; Alper Kepez; Halil Atas; Haner Direskeneli; Yelda Basaran
Journal:  Wien Klin Wochenschr       Date:  2013-07-12       Impact factor: 1.704

Review 2.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

3.  Attenuated nitric oxide bioavailability in systemic sclerosis: Evidence from the novel assessment of passive leg movement.

Authors:  Heather L Clifton; Daniel R Machin; H Jonathan Groot; Tracy M Frech; Anthony J Donato; Russell S Richardson; D Walter Wray
Journal:  Exp Physiol       Date:  2018-08-18       Impact factor: 2.969

Review 4.  A vascular mechanistic approach to understanding Raynaud phenomenon.

Authors:  Nicholas A Flavahan
Journal:  Nat Rev Rheumatol       Date:  2014-12-23       Impact factor: 20.543

Review 5.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

Review 6.  Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Karen Au; Manjit K Singh; Vijay Bodukam; Sangmee Bae; Paul Maranian; Rikke Ogawa; Brennan Spiegel; Maureen McMahon; Bevra Hahn; Dinesh Khanna
Journal:  Arthritis Rheum       Date:  2011-07

7.  Association between endothelial function and microvascular changes in patients with secondary Raynaud's phenomenon.

Authors:  Ji Hyun Le; Kyoung Im Cho
Journal:  Clin Rheumatol       Date:  2014-03-11       Impact factor: 2.980

Review 8.  Cardiovascular disease in systemic sclerosis.

Authors:  Francesca Cannarile; Valentina Valentini; Giulia Mirabelli; Alessia Alunno; Riccardo Terenzi; Filippo Luccioli; Roberto Gerli; Elena Bartoloni
Journal:  Ann Transl Med       Date:  2015-01

9.  Vascular endothelial injury assessed with functional techniques in systemic sclerosis patients with pulmonary arterial hypertension versus systemic sclerosis patients without pulmonary arterial hypertension: a systematic review and meta-analysis.

Authors:  Marieta P Theodorakopoulou; Ioanna Minopoulou; Pantelis Sarafidis; Vassilios Kamperidis; Christodoulos Papadopoulos; Theodoros Dimitroulas; Afroditi K Boutou
Journal:  Rheumatol Int       Date:  2021-04-08       Impact factor: 2.631

10.  Efficacy of cilostazol for the treatment of Raynaud's phenomenon in systemic sclerosis patients.

Authors:  Simone Negrini; Francesca Spanò; Elena Penza; Daniela Rollando; Francesco Indiveri; Gilberto Filaci; Francesco Puppo
Journal:  Clin Exp Med       Date:  2015-06-19       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.